How to Buy Mink Therapeutics Stock
Mink Therapeutics Inc
MiNK Therapeutics, Inc. , a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases.
Mink Therapeutics stock last closed at $0.95, down 3.74% from the previous day, and has decreased 12.57% in one year. It has overperformed other stocks in the Biotechnology industry by 0.08 percentage points. Mink Therapeutics stock is currently +27.07% from its 52-week low of $0.75, and -71.47% from its 52-week high of $3.34.
As of May 1, 2024, there are 34.7M INKT shares outstanding. The market value of INKT is $33.07M. In the last 24 hours, 79,937 INKT shares were traded.
How to Buy Mink Therapeutics Stock
Wondering how to invest in Mink Therapeutics stock? Here's how.
- Decide where to buy Mink Therapeutics stock: You need to decide on an online brokerage, but don't worry - we've tried dozens of online stock brokerages and apps to help you figure out where to buy Mink Therapeutics stock.
- Create a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've found.
- Deposit funds into your brokerage account: Select your method of payment and add your information.
- Evaluate Mink Therapeutics stock: The Mink Therapeutics ticker symbol is INKT. Is Mink Therapeutics stock a good investment? Should you buy shares of INKT? How do INKT's underlying business fundamentals look? Do top analysts think Mink Therapeutics is a good buy? Why has INKT's stock price moved recently? (Hint: Our stock analysis website can help you evaluate if INKT is a good stock to buy).
- Make your INKT buy order: Decide if you will purchase INKT shares at the current market price or use a limit order to purchase INKT shares at a specific price.
- Keep an eye on your INKT investment: Create a watchlist to watch your investment in Mink Therapeutics shares.
Step 1: Decide where to buy Mink Therapeutics stock
You need a brokerage account to access the NASDAQ market and buy INKT stock.
Our recommended brokerage: eToro
Based on our experience, eToro is the best stock brokerage. eToro gives you:
- Invest in stocks with zero commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still buy the stock.
- Access to global markets: From Tech to Industrials, New York to Hong Kong — you can fill your portfolio with stocks from the globe's leading stock exchanges.
- Social investing: eToro boasts a community of more than 20 million users globally. Talk to, learn from, and copy the unique crypto portfolios of top investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other assets: Such as ETFs and cryptos.
Get $10 towards your share purchase by opening an account with eToro now.
Open eToro AccountStep 2: Create a brokerage account
Now that you've selected the best brokerage, you need to fill out some personal info so you can invest in INKT stock today.
How to Create a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal info to start your new trading account.
- Send your data by hitting the "Create Account" button. Get started with eToro today
Step 3: Deposit funds into your brokerage account
Now that you've finished signing up on the best investment app, your next step is to transfer the money for your investment:
Check out the tutorial below for more details depositing funds into your brokerage account.
Step 4: Evaluate Mink Therapeutics stock
After you have figured out the best place to buy Mink Therapeutics stock, it's absolutely critical to analyze their stock before you invest, so you actually wrap your head around the risk as well as the opportunity.
Overview of key INKT info
Mink Therapeutics Zen Score
WallStreetZen was built to help everyday investors do more in-depth fundamental analysis.
You can view all of the due diligence checks on INKT's stock page.
Is INKT stock properly valued?
Analysts use many financial metrics, analyses, models, and charts to gauge INKT's fair value.
You can access more valuation research on INKT's stock here.
INKT Financial Health
Cons:
- Total INKT debt is still negative.
- There are more long-term liabilities than short-term assets on the INKT balance sheet.
- INKT debt to equity ratio of -1.25 is negative.
- There are more short-term liabilities than short-term assets on the INKT balance sheet.
- INKT has $3.37M in cash and short term investments. This is not sufficient to cover its annual cash burn of $15.84M.
- INKT has cash burn of 15836073. It does not have sufficient cash and short-term investments to cover this.
Do Wall Street analysts think it's a good time to buy Mink Therapeutics stock
Out of 1 Equities analysts who give forecasts on INKT, the consensus analyst rating on INKT is a Buy
Please note that analyst ratings are not recommendations, nor are they financial advice.
You can dive deeper into what analysts are saying on the Mink Therapeutics stock forecast page.
INKT Trading Indicators
INKT Revenue
Last year, INKT revenue was $0.00. Over the last 4 year, INKT's revenue has gone up by -100% per year. This was slower than the Biotechnology industry average of 28.49%.
Dig into INKT's earnings and revenue performance here.
Latest Insiders Trades at INKT
In the past 12 months, executives and large shareholders at INKT have bought more shares than they have sold.
Peter Behner, Director of INKT, was the latest INKT insider to buy. They bought $15,375.75 worth of INKT shares on Mar 1, 2024.
Dig into more about who owns INKT stock here.
Does INKT stock generate passive income?
No, Mink Therapeutics doesn't provide an income stream by paying out dividends.
Get opinions from other investors
One of the primary reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to learn what other community members have to say.
Step 5: Make your INKT buy order
There are two primary types of orders:
- Market order: A market order is an order to buy or sell a security at the best available price.
Market orders are generally the easiest way to buy. - Limit order: A limit order allows you to buy or sell a stock at a specific price (or better).
If you want to be certain you're buying or selling at an exact dollar amount limit, place a limit order.
Hit the Open Trade button and your broker will execute the order.
If you want more assistance investing in stocks on eToro, watch the helpful video below:
Step 6: Keep an eye on your INKT investment
Now that you own some INKT stock, you'll want to stay up-to-date on your company.
Add INKT to a watchlist to get notified of important updates regarding your INKT stock.
INKT Feed
How to Buy Stock in Mink Therapeutics
To summarize, here are the 6 steps you need to take to buy Mink Therapeutics stock right now:
- Decide where to buy Mink Therapeutics stock
- Create a brokerage account
- Deposit funds into your brokerage account
- Evaluate Mink Therapeutics stock
- Make your INKT buy order
- Keep an eye on your INKT investment
If you are looking for a online brokerage, eToro is our recommended venue.
Get Started with eToro TodayIf you want to get the latest news on your investment in Mink Therapeutics, get started below.
Other Articles You Might Like
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.